Trumenba (Wyeth Pharmaceutical Division of Wyeth Holdings LLC, a subsidiary of Pfizer Inc.)
Welcome to the PulseAid listing for the Trumenba drug offered from Wyeth Pharmaceutical Division of Wyeth Holdings LLC, a subsidiary of Pfizer Inc.. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
| LABELER NAME / MANUFACTURER: | Wyeth Pharmaceutical Division of Wyeth Holdings LLC, a subsidiary of Pfizer Inc. |
| NON-PROPRIETARY NAME: | meningococcal group B vaccine |
| SUBSTANCE NAME: | NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN; NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN |
| TYPE: | VACCINE |
| PHARMA CLASS: | |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION, SUSPENSION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2014-11-05 |
| END MARKETING DATE: | 0000-00-00 |
Trumenba VACCINE Details:
| Item Description | Trumenba from Wyeth Pharmaceutical Division of Wyeth Holdings LLC, a subsidiary of Pfizer Inc. |
| LABELER NAME: | Wyeth Pharmaceutical Division of Wyeth Holdings LLC, a subsidiary of Pfizer Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 60; 60(ug/.5mL; ug/.5mL) |
| START MARKETING DATE: | 2014-11-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0005-0100_b19a04ed-e240-417c-9527-cbe644cb71a4 |
| PRODUCT NDC: | 0005-0100 |
| APPLICATION NUMBER: | BLA125549 |
Other NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN; NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN Pharmaceutical Manufacturers / Labelers:
